The plant, which will produce insulin-based treatments for China and other markets in Asia, will be the company's biggest ever investment outside its home country.
該工廠將為中國和亞洲其它市場生產胰島素類產品,是諾和諾德迄今最大的一筆海外投資。
您已閱讀16%(203字),剩余84%(1062字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。